‘MicroRNA‐92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer,’ by Zeng‐Hui Li, Lei Li, Lin‐Ping Kang, and Yan Wang, Cancer Medicine 2018; 7(7): 3118– 3131. The above article, published online on May 11, 2018 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1002/cam4.1329) has been retracted by agreement between the the journal’s Editor in Chief and Wiley Periodicals LLC. The retraction has been agreed following an investigation based on allegations raised by a third party. A detailed investigation revealed that several image elements of the experimental data (figures 2B and 4B) were published elsewhere in a different scientific context. Furthermore, several methodical flaws and inconsistencies were found. Thus, the editor considers the conclusions of this article to be invalid. The authors were not available to comment on these inconsistencies.
. 2021 Sep 27;10(20):7440. doi: 10.1002/cam4.4265
Retraction
Collection date 2021 Oct.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC8525112 PMID: 34569716
This retracts the article "MicroRNA‐92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer" in volume 7 on page 3118.
